| Year |
Citation |
Score |
| 2019 |
Zhu Z, Duan X, Tu J. Relative Strength over Investment Horizons and Stock Returns The Journal of Portfolio Management. 46: 91-105. DOI: 10.3905/Jpm.2019.1.111 |
0.331 |
|
| 2019 |
Chiang C, Dai W, Fan J, Hong HG, Tu J. Robust Measures of Earnings Surprises Journal of Finance. 74: 943-983. DOI: 10.1111/Jofi.12746 |
0.303 |
|
| 2017 |
Chen J, Jiang F, Liu Y, Tu J. International volatility risk and Chinese stock return predictability Journal of International Money and Finance. 70: 183-203. DOI: 10.1016/J.Jimonfin.2016.08.007 |
0.352 |
|
| 2016 |
Qian LY, Tu JF, Ding YH, Pang J, Che XD, Zou H, Huang DS. Association of blood pressure level with nonalcoholic fatty liver disease in nonhypertensive population: Normal is not the new normal. Medicine. 95: e4293. PMID 27442673 DOI: 10.1097/MD.0000000000004293 |
0.378 |
|
| 2015 |
Huang D, Jiang F, Tu J, Zhou G. Investor sentiment aligned: : A powerful predictor of stock returns Review of Financial Studies. 28: 791-837. DOI: 10.2139/Ssrn.2311618 |
0.536 |
|
| 2014 |
Zhai W, Zhang J, Yang Y, Ma C, Liu Z, Gao C, Zhou G, Tu J, Shen J, Fu T. Gene expression and genetic analysis reveal diverse causes of recessive self-compatibility in Brassica napus L. Bmc Genomics. 15: 1037. PMID 25432521 DOI: 10.1186/1471-2164-15-1037 |
0.32 |
|
| 2014 |
Chen J, Jiang F, Tu J. Asset Allocation in the Chinese Stock Market: The Role of Return Predictability The Journal of Portfolio Management. 41: 71-83. DOI: 10.3905/Jpm.2015.41.5.071 |
0.345 |
|
| 2014 |
Neely CJ, Rapach DE, Tu J, Zhou G. Forecasting the equity risk premium: The role of technical indicators Management Science. 60: 1772-1791. DOI: 10.1287/Mnsc.2013.1838 |
0.455 |
|
| 2013 |
Goh JC, Jiang F, Tu J, Wang Y. Can US Economic Variables Predict the Chinese Stock Market Pacific-Basin Finance Journal. 22: 69-87. DOI: 10.1016/J.Pacfin.2012.10.002 |
0.344 |
|
| 2011 |
Tu J, Zhou G. Markowitz meets Talmud: A combination of sophisticated and naive diversification strategies ☆ Journal of Financial Economics. 99: 204-215. DOI: 10.1016/J.Jfineco.2010.08.013 |
0.416 |
|
| 2010 |
Tu J, Zhou G. Incorporating Economic Objectives into Bayesian Priors: Portfolio Choice Under Parameter Uncertainty Journal of Financial and Quantitative Analysis. 45: 959-986. DOI: 10.1017/S0022109010000335 |
0.452 |
|
| 2009 |
Chen Y, Tu JH, He YJ, Zhang W, Wang G, Tan ZR, Zhou G, Fan L, Zhou HH. Effect of sodium tanshinone II A sulfonate on the activity of CYP1A2 in healthy volunteers. Xenobiotica; the Fate of Foreign Compounds in Biological Systems. 39: 508-13. PMID 19534587 DOI: 10.1080/00498250902951763 |
0.356 |
|
| 2009 |
He YJ, Zhang W, Chen Y, Guo D, Tu JH, Xu LY, Tan ZR, Chen BL, Li Z, Zhou G, Yu BN, Kirchheiner J, Zhou HH. Rifampicin alters atorvastatin plasma concentration on the basis of SLCO1B1 521T>C polymorphism. Clinica Chimica Acta; International Journal of Clinical Chemistry. 405: 49-52. PMID 19374892 DOI: 10.1016/j.cca.2009.04.003 |
0.337 |
|
| 2009 |
Chen Y, Xiao P, Ou-Yang DS, Fan L, Guo D, Wang YN, Han Y, Tu JH, Zhou G, Huang YF, Zhou HH. Simultaneous action of the flavonoid quercetin on cytochrome P450 (CYP) 1A2, CYP2A6, N-acetyltransferase and xanthine oxidase activity in healthy volunteers. Clinical and Experimental Pharmacology & Physiology. 36: 828-33. PMID 19215233 DOI: 10.1111/j.1440-1681.2009.05158.x |
0.355 |
|
| 2007 |
Hu YF, Tu JH, Tan ZR, Liu ZQ, Zhou G, He J, Wang D, Zhou HH. Association of CYP3A4*18B polymorphisms with the pharmacokinetics of cyclosporine in healthy subjects. Xenobiotica; the Fate of Foreign Compounds in Biological Systems. 37: 315-27. PMID 17624028 DOI: 10.1080/00498250601149206 |
0.335 |
|
| 2007 |
Hong Y, Tu J, Zhou G. Asymmetries in Stock Returns: Statistical Tests and Economic Evaluation Review of Financial Studies. 20: 1547-1581. DOI: 10.1093/Rfs/Hhl037 |
0.455 |
|
| 2006 |
Hu YF, Qiu W, Liu ZQ, Zhu LJ, Liu ZQ, Tu JH, Wang D, Li Z, He J, Zhong GP, Zhou G, Zhou HH. Effects of genetic polymorphisms of CYP3A4, CYP3A5 and MDR1 on cyclosporine pharmacokinetics after renal transplantation. Clinical and Experimental Pharmacology & Physiology. 33: 1093-8. PMID 17042920 DOI: 10.1111/j.1440-1681.2006.04492.x |
0.351 |
|
| 2004 |
Tu J, Zhou G. Data-generating process uncertainty: What difference does it make in portfolio decisions? Journal of Financial Economics. 72: 385-421. DOI: 10.1016/J.Jfineco.2003.05.003 |
0.432 |
|
| Show low-probability matches. |